MARKET

ADMA

ADMA

Adma Biologics
NASDAQ
6.46
-0.08
-1.22%
After Hours: 6.55 +0.09 +1.39% 19:05 04/24 EDT
OPEN
6.54
PREV CLOSE
6.54
HIGH
6.55
LOW
6.42
VOLUME
1.72M
TURNOVER
0
52 WEEK HIGH
6.76
52 WEEK LOW
3.060
MARKET CAP
1.50B
P/E (TTM)
-51.2292
1D
5D
1M
3M
1Y
5Y
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?
NASDAQ · 14h ago
Corcept (CORT) Posts Positive Data From Cushing's Syndrome Study
NASDAQ · 1d ago
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
NASDAQ · 1d ago
Will Alkermes' (ALKS) Proprietary Drugs Aid Amid Competition?
NASDAQ · 2d ago
Weekly Report: what happened at ADMA last week (0415-0419)?
Weekly Report · 2d ago
Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug
NASDAQ · 5d ago
Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal
NASDAQ · 6d ago
DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch
NASDAQ · 6d ago
More
About ADMA
ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The Company manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV (immune globulin intravenous, human - slra 10% liquid) for the treatment of PI, and NABI-HB (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. Through its ADMA BioCenters subsidiary, the Company also operates as an FDA-approved source plasma collector in the United States, which provides its blood plasma for the manufacture of its products.

Webull offers ADMA Biologics Inc stock information, including NASDAQ: ADMA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADMA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADMA stock methods without spending real money on the virtual paper trading platform.